Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
1.910
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Esperion Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -22.68 | -51.75 | -209.25 | -233.66 | -269.11 | Upgrade
|
| Depreciation & Amortization | 0.11 | 0.06 | 0.16 | 0.5 | 0.61 | Upgrade
|
| Other Amortization | 3.01 | 1.5 | 1.7 | 1.62 | 1.62 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.41 | 0.28 | 0.01 | Upgrade
|
| Stock-Based Compensation | 9.87 | 11.99 | 11.96 | 15.22 | 24.31 | Upgrade
|
| Other Operating Activities | 11.25 | 75.07 | 46.68 | 44.59 | 31.26 | Upgrade
|
| Change in Accounts Receivable | -60.05 | -31.65 | -14.77 | -10.8 | -10.55 | Upgrade
|
| Change in Inventory | -10.63 | -28.87 | -30.42 | -0.81 | -18.26 | Upgrade
|
| Change in Accounts Payable | 20.92 | 12.43 | 8.68 | 5.6 | -34.1 | Upgrade
|
| Change in Unearned Revenue | 25.96 | -16.88 | 21.9 | -2.81 | 4.66 | Upgrade
|
| Change in Other Net Operating Assets | 9.16 | 4.44 | 28.29 | 5.44 | 5.74 | Upgrade
|
| Operating Cash Flow | -13.09 | -23.65 | -135.49 | -174.83 | -263.81 | Upgrade
|
| Capital Expenditures | - | -0.32 | - | - | - | Upgrade
|
| Investment in Securities | - | - | 42.5 | 8.1 | -50.48 | Upgrade
|
| Investing Cash Flow | - | -0.32 | 42.5 | 8.1 | -50.48 | Upgrade
|
| Long-Term Debt Issued | - | 99.73 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -54.91 | -210.09 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -54.91 | -110.36 | - | - | - | Upgrade
|
| Issuance of Common Stock | 98.35 | 105.99 | 65.95 | 90.85 | 222.45 | Upgrade
|
| Repurchase of Common Stock | - | -343.75 | - | -50 | - | Upgrade
|
| Other Financing Activities | -7.26 | 434.6 | -15.49 | -8.24 | 45.77 | Upgrade
|
| Financing Cash Flow | 36.18 | 86.48 | 50.46 | 32.61 | 268.22 | Upgrade
|
| Net Cash Flow | 23.09 | 62.51 | -42.53 | -134.12 | -46.07 | Upgrade
|
| Free Cash Flow | -13.09 | -23.97 | -135.49 | -174.83 | -263.81 | Upgrade
|
| Free Cash Flow Margin | -3.25% | -7.21% | -116.46% | -231.64% | -336.29% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.13 | -1.31 | -2.63 | -9.13 | Upgrade
|
| Cash Interest Paid | - | 5.83 | 15.51 | 8.02 | - | Upgrade
|
| Levered Free Cash Flow | -52.59 | -65.72 | -129.64 | -135.56 | -192.19 | Upgrade
|
| Unlevered Free Cash Flow | -2.72 | -30.18 | -94.48 | -101.67 | -164.84 | Upgrade
|
| Change in Working Capital | -14.64 | -60.53 | 13.68 | -3.37 | -52.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.